// NEWS RELEASE

Top AMC Civilian Takes Stock of ECBC Capabilities and Expertise

The top civilian official from the U.S. Army Materiel Command visits ECBC.

CCDC Chemical Biological Center Public Affairs | March 31st, 2016

// NEWS RELEASE

Top AMC Civilian Takes Stock of ECBC Capabilities and Expertise

The top civilian official from the U.S. Army Materiel Command visits ECBC.

CCDC Chemical Biological Center Public Affairs | March 31st, 2016

// NEWS RELEASE

Top AMC Civilian Takes Stock of ECBC Capabilities and Expertise

The top civilian official from the U.S. Army Materiel Command visits ECBC.

CCDC Chemical Biological Center Public Affairs | March 31st, 2016

Top AMC Civilian Takes Stock of ECBC Capabilities and Expertise

The top civilian official from the U.S. Army Materiel Command visits ECBC.

DEVCOM CBC Public Affairs
March 31st, 2016

Top AMC Civilian Takes Stock of ECBC Capabilities and Expertise

Dave Caretti, an ECBC research physiologist, shows Lisha Adams, Executive Deputy to the Army Materiel Command’s Commanding General, the Integrated Respiratory and Eye Protection Scarf, or IREPS, which he co-invented.

The top civilian official from the Army command responsible for equipping, sustaining and enabling the warfighter learned more about the mission and capabilities of the U.S. Army Edgewood Chemical Biological Center on March 31.

Ms. Lisha Adams, executive deputy to the commanding general of the U.S. Army Materiel Command, toured ECBC’s Advanced Chemistry Laboratory and got a first-hand look at the latest technology being developed by the Center.

The tour included an overview briefing from the Center’s senior leadership, a threat briefing, and a tour of the Synthesis Laboratory, which is designed to analyze and evaluate emerging chemical and biological threats. The tour concluded with a hands-on familiarization of three examples of cutting-edge chemical-biological defense technology — the Integrated Respiratory and Eye Protection Scarf, the Tactical Biological Generation II Detector, and a biological spore-killing decontamination gel.

“Ms. Adams’ visit was valuable to ECBC because that’s how our command leadership learns about our unique contribution to protecting the warfighter,” said Peter Emanuel, Ph.D., ECBC Biosciences Division chief and acting Research and Technology director. “She gained an appreciation of the depth of our expertise and our dedication to safety.”

Director of Program Integration Paul Tanenbaum, Ph.D. added, “Ms. Adams was also able to learn about the extent to which we leverage our effectiveness by collaborating with other Army agencies, federal agencies such as the Department of Homeland Security and the Federal Bureau of Investigation, research universities, and technology companies.”

The directors accomplished their goal of showing Adams the value of ECBC’s contributions to our nation’s defense. Summing up her visit, Adams said, “ECBC truly is the foundation of the nation’s chemical and biological defense. I was impressed to learn about the breadth of their mission and expertise, and to see their dedication to putting the latest chemical biological defense technology into the hands of our warfighters. The nation is safer for the work they do.”


The U.S. Army Combat Capabilities Development Command (DEVCOM) leads in the discovery, development and delivery of technology-based capabilities to enable Soldiers to win our nation’s wars and come home safely. DEVCOM is a major subordinate command of the U.S. Army Futures Command. The DEVCOM Chemical Biological Center is the Army’s principal research and development center for chemical and biological defense technology, engineering and field operations. The DEVCOM Chemical Biological Center is headquartered at Aberdeen Proving Ground, Maryland.